or Try an Advanced Search...

    Janus Kinase Inhibitor Stocks List

    Symbol Grade Name % Change
    ARGX F argenx SE 1.31
    INCY F Incyte Corporation 0.74
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Inflammation Solid Tumors Acute Myeloid Leukemia Autoimmune Disease Cancer Cancer Immunotherapy Chemical Compounds Clinical Trial Product Clinical Trial Products Diabetic Nephropathy Dyslipidemia Hematologic Malignancies Hematological Cancers Immunotherapy Lipid Lymphoma Morpholines Myasthenia Myasthenia Gravis

    Related ETFs - A few ETFs which own one or more of the above listed Janus Kinase Inhibitor stocks.

    Symbol Grade Name Weight
    EWK B iShares MSCI Belgium Capped Investable Market Index Fund 6.71
    FBT D First Trust Amex Biotech Index Fund 6.55
    BBH D Market Vectors Biotech ETF 6.37
    IBRN D iShares Neuroscience and Healthcare ETF 4.54
    IDNA D iShares Genomics Immunology and Healthcare ETF 3.79
    View all Janus Kinase Inhibitor ETFs...
    Compare ETFs
    Compare EWK to FBT Compare EWK to IDNA Compare FBT to IDNA

        Janus Kinase Inhibitor Stocks Recent News

        Date Stock Title
        Apr 25 INCY Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
        Apr 24 INCY Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy?
        Apr 23 INCY Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
        Apr 23 INCY Incyte (INCY) Earnings Expected to Grow: Should You Buy?
        Apr 23 INCY Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
        Apr 23 INCY Incyte to acquire immune-focused drug developer Escient
        Apr 23 INCY Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Inflammation Solid Tumors Acute Myeloid Leukemia Autoimmune Disease Cancer Cancer Immunotherapy Chemical Compounds Clinical Trial Product Clinical Trial Products Diabetic Nephropathy Dyslipidemia Hematologic Malignancies Hematological Cancers Immunotherapy Lipid Lymphoma Morpholines Myasthenia Myasthenia Gravis
        Janus Kinase Inhibitor

        Janus kinase (JAK) inhibitors are a class of drugs that block the activity of Janus kinases, a family of enzymes involved in signaling pathways that regulate the activity of the immune system. JAK inhibitors are used to treat autoimmune diseases such as rheumatoid arthritis, psoriasis, and ulcerative colitis. They work by blocking the activity of JAK enzymes, which prevents them from activating the immune system and causing inflammation.

        Browse All Tags